Showing 1 - 10 of 46
Von der Biotechnologie erhofft man sich Verbesserung hinsichtlich der Lebensqualität der Menschen sowie ein Wachstum von Wirtschaft und Arbeitsplätzen. Aufgrund der technologischen Risiken und der mit dem Einsatz der Biotechnologie und der Gentechnik verbundenen moralischen Konflikte fordern...
Persistent link: https://www.econbiz.de/10009433729
This study deals with the post-acquisition integration of small biotechnology firms into the structure of large pharmaceutical companies. In this context, pharmaceutical companies face the paradox, that they need to integrate the biotechnology companies in some way in order to get access to the...
Persistent link: https://www.econbiz.de/10009480992
Die Bezeichnung 'Business Development' ist in modernen High-Tech-Industrien wie der Biotechnologie-Industrie mittlerweile sehr popul?r geworden. W?hrend bekannt ist, welche strategischen Entwicklungsoptionen f?r eine Unternehmensentwicklung potentiell zur Verf?gung stehen, wei? man jedoch nur...
Persistent link: https://www.econbiz.de/10009480999
The field of biotechnology is diverse and the industry is immature in comparison toother sectors. Biotechnology represents the convergence of biology, computerscience, chemistry, physics, and engineering, working in synergy (Cardinal & Opler,1995). This industry is a starting point for utilising...
Persistent link: https://www.econbiz.de/10009447844
This study examines whether changes in the amount of unrecognised deferred tax assets from carry forward losses, determined in accordance with AASB1020 ‘Accounting for Income Taxes’, reflect managers’ incentives to opportunistically manage financial statements, or communicate private...
Persistent link: https://www.econbiz.de/10009448697
Full-text of this article is not available in this e-prints service. This article was originally published following peer-review in Journal of Information & Knowledge Management, published by and copyright World Scientific Publishing Co.
Persistent link: https://www.econbiz.de/10009455152
University of Miinesoota Ph.D. dissertation. February 2011. Major: Business Administration. Advisor: J. Myles Shaver. 1 computer file (PDF); x, 152 p. appendix p. 128-152.
Persistent link: https://www.econbiz.de/10009462758
Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...
Persistent link: https://www.econbiz.de/10009434765
The pharmaceutical industry invests its sales force in contacts with doctors, making visits and publicizing its drugs, in orderfor them to prescribe these products to their patients. This work discusses the structure of the pharmaceutical market and howmarketing strategies are used by...
Persistent link: https://www.econbiz.de/10009446936
IN 1984, Congress enacted a new law that greatly affected the economicsof the pharmaceutical industry in the United States. It has been characterizedas the most important legislation affecting competition in the pharmaceuticalindustry since the 1962 Kefauver-Harris Amendments to theFood and Drug...
Persistent link: https://www.econbiz.de/10009475542